drugset / Trial / NCT00528541

Comparison of Efficacy and Safety of Two Different Types of Botulinum Toxin Type A in Moderate to Severe Cervical Dystonia

NCT00528541

Phase 4 Completed 145 enrolled Allergan
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to compare two types of botulinum toxin type A to treat the involuntary muscle contractions in the neck

Timeline

Start
2007-09
Primary completion
2009-09
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic 200 iu
Comparator Botulinum toxin type A Protein / enzyme biologic 750 iu

Indications